| Ruthenium–arene complexes with NSAIDs: synthesis, characterization and bioactivity A Tadić, J Poljarević, M Krstić, M Kajzerberger, S Aranđelović, ... New Journal of Chemistry 42 (4), 3001-3019, 2018 | 31 | 2018 |
| Telmisartan induces melanoma cell apoptosis and synergizes with vemurafenib in vitro by altering cell bioenergetics J Grahovac, T Srdić-Rajić, JF Santibañez, M Pavlović, M Čavić, ... Cancer Biology & Medicine 16 (2), 247-263, 2019 | 29 | 2019 |
| Exploring the real-world effect of the SARS-CoV-2 pandemic on the molecular diagnostics for cancer patients and high-risk individuals M Cavic, A Krivokuca, I Boljevic, J Spasic, M Mihajlovic, M Pavlovic, ... Expert Review of Molecular Diagnostics 21 (1), 101-107, 2021 | 17 | 2021 |
| Synthesis, chemical characterization, PARP inhibition, DNA binding and cellular uptake of novel ruthenium (II)-arene complexes bearing benzamide derivatives in human breast … M Pavlović, A Tadić, N Gligorijević, J Poljarević, T Petrović, B Dojčinović, ... Journal of Inorganic Biochemistry 210, 111155, 2020 | 16 | 2020 |
| New organoruthenium compounds with pyrido[2',3':5,6]pyrazino[2,3-f][1, 10]phenanthroline: synthesis, characterization, cytotoxicity, and investigation of mechanism of action M Pavlovic, S Nikolic, N Gligorijevic, B Dojcinovic, S Arandjelovic, ... Journal of Biological Inorganic Chemistry 24 (2), 297-310, 2019 | 16 | 2019 |
| EGFR mutation testing from liquid biopsy of non-small cell lung cancer at the Institute for Oncology and Radiology of Serbia M Cavic, A Krivokuca, M Pavlovic, I Boljevic, J Rakobradovic, M Mihajlovic, ... J BUON 25 (6), 2635-2642, 2020 | 10 | 2020 |
| Tumor selective Ru (III) Schiff bases complexes with strong in vitro activity toward cisplatin-resistant MDA-MB-231 breast cancer cells M Pavlović, E Kahrović, S Aranđelović, S Radulović, PP Ilich, ... JBIC Journal of Biological Inorganic Chemistry, 1-22, 2023 | 6 | 2023 |
| New ruthenium (II) bipyridyl complex: Synthesis, crystal structure and cytotoxicity AA Baroud, LE Mihajlović-Lalić, DM Stanković, M Kajzerberger, ... Journal of the Serbian Chemical Society 82 (3), 267-275, 2017 | 4 | 2017 |
| EGFR mutation testing from pleural effusions of non-small cell lung cancer patients at the institute for oncology and radiology of Serbia M Vukovic, M Tanic, A Damjanovic, M Pavlovic, A Stanojevic, K Zivic, ... Translational Oncology 37, 101772, 2023 | 2 | 2023 |
| 1731P Molecular diagnostics for cancer patients and high-risk individuals during the SARS-CoV-2 pandemic at the Institute for Oncology and Radiology of Serbia M Cavic, A Krivokuca, A Damjanovic-Velickovic, M Pavlovic, M Mihajlovic, ... Annals of Oncology 31, S1014, 2020 | 1 | 2020 |
| P1. 03-07 Advantages and Setbacks of EGFR Mutation Testing from Liquid Biopsy of Advanced Lung Adenocarcinoma Patients in Serbia J Spasic, A Krivokuca, I Boljevic, M Pavlovic, J Rakobradovic, V Jokic, ... Journal of Thoracic Oncology 14 (10), S419-S420, 2019 | 1 | 2019 |
| Nischarin is a potential druggable target in both epithelial and stromal compartments of pancreatic ductal adenocarcinoma J Grahovac, K Živić, M Pavlović, M Ostojić, A Đurić, T Srdić-Rajić, A Pavić, ... Cancer Research 83 (7_Supplement), 2476-2476, 2023 | | 2023 |
| Preclinical validation of rilmenidine for repurposing in pancreatic ductal adenocarcinoma J Grahovac, K Živić, M Pavlović, M Ostojić, A Đurić, T Srdić Rajić, A Pavić, ... Molecular oncology 17 (Supplement 1), 347-348, 2023 | | 2023 |
| 953P EGFR mutation testing from pleural effusions of advanced lung adenocarcinoma patients in Serbia M Cavic, A Damjanovic, I Boljevic, M Pavlovic, A Stefanovic, K Zivic, ... Annals of Oncology 33, S983, 2022 | | 2022 |
| Nischarin agonist rilmenidine inhibits pancreatic ductal adenocarcinoma cell migration and invasion M Pavlovic, M Ostojic, K Zivic, A Pavic, T Srdic-Rajic, J Grahovac Cancer Research 82 (12_Supplement), 3463-3463, 2022 | | 2022 |
| Abstract PO-040: Nischarin is expressed in pancreatic ductal adenocarcinoma and is a potential target for drug repurposing J Grahovac, M Pavlovic, M Ostojic, K Zivic, D Galun, T Srdic-Rajic Cancer Research 81 (22 Supplement), PO-040-PO-040, 2021 | | 2021 |
| Nischarin is expressed in pancreatic ductal adenocarcinoma and is a potential target for drug repurposing. J Grahovac, M Pavlovic, M Ostojic, K Zivic, D Galun, T Srdic-Rajic CANCER RESEARCH 81 (22), 28-28, 2021 | | 2021 |
| Antitumorski potencijal novosintetisanih rutenijum (II)-arenskih kompleksa sa bioaktivnim ligandima in vitro MS Pavlović Univerzitet u Beogradu-Biološki fakultet, 2021 | | 2021 |
| A Fluorescence-Based Assay for Measuring Glucose Uptake in Living Melanoma Cells J Grahovac, M Pavlović, M Ostojić Melanoma, 73-80, 2021 | | 2021 |
| Synthesis, chemical characterization, PARP inhibition, DNA binding and cellular uptake of novel ruthenium (II)-arene complexes bearing benzamide derivatives in human breast … M Pavlovic, A Tadic, N Gligorijevic, J Poljarevic, T Petrovic, B Dojcinovic, ... JOURNAL OF INORGANIC BIOCHEMISTRY 210, 2020 | | 2020 |
